KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Edwards Lifesciences (EW) Receivables - Net (2016 - 2025)

Edwards Lifesciences has reported Receivables - Net over the past 17 years, most recently at $659.6 million for Q4 2025.

  • Quarterly results put Receivables - Net at $659.6 million for Q4 2025, up 2190.28% from a year ago — trailing twelve months through Dec 2025 was $659.6 million (up 2190.28% YoY), and the annual figure for FY2025 was $659.6 million, up 2190.28%.
  • Receivables - Net for Q4 2025 was $659.6 million at Edwards Lifesciences, down from $693.3 million in the prior quarter.
  • Over the last five years, Receivables - Net for EW hit a ceiling of $817.6 million in Q1 2024 and a floor of $28.8 million in Q4 2024.
  • Median Receivables - Net over the past 5 years was $664.4 million (2025), compared with a mean of $649.3 million.
  • Biggest five-year swings in Receivables - Net: tumbled 96.27% in 2024 and later surged 2190.28% in 2025.
  • Edwards Lifesciences' Receivables - Net stood at $582.2 million in 2021, then increased by 10.44% to $643.0 million in 2022, then grew by 19.98% to $771.5 million in 2023, then tumbled by 96.27% to $28.8 million in 2024, then surged by 2190.28% to $659.6 million in 2025.
  • The last three reported values for Receivables - Net were $659.6 million (Q4 2025), $693.3 million (Q3 2025), and $697.0 million (Q2 2025) per Business Quant data.